MabDesign

Platinum Sponsor

MabDesign the French association of the immunotherapy industrial sector, aims to support, structure, federate and increase the visibility of the industrial immunotherapy sector, foster exchanges and stimulate innovation.

To achieve this goal, MabDesign sets up a coherent set of actions promoting exchanges, collaborations and skills development of the sector stakeholders. In this dynamic MabDesign has developed a national directory that brings together industrial and academic players in immunotherapy and allows to identify online the know-how available in France. Several times a year, MabDesign also organizes high-level national or international scientific events, in collaboration with key ecosystem players, to highlight innovation and stimulate exchanges on scientific issues. Finally, MabDesign offers specialized and innovative continuing professional training solutions to enable companies to adapt their skills needed to the latest knowledge in immunotherapy.

MabDesign places the economic development of companies at the heart of its ambition. To this end, MabDesign provides its members with a wide range of services to help them optimize their positioning, protect and enhance their innovations, and conquer new international markets.

Finally, to promote the development and production of biomedicines on the territory, MabDesign is involved in various government actions around bioproduction.

Operational since September 2015, MabDesign currently counts more than 150 member companies, including pharmaceutical and biotechnology companies, service providers, training organizations and high-tech equipment suppliers.

Come and meet MabDesign at booths 1, 3, 5B and 6 and discover the know-how of 16 company members present this year at the Festival of Biologics

contact@mabdesign.fr

www.mabdesign.fr

 




website

Festibval of Biologics

 

There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.